These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22674531)

  • 1. CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer.
    Lee HH; Seo KJ; An CH; Kim JS; Jeon HM
    J Surg Oncol; 2012 Dec; 106(8):999-1004. PubMed ID: 22674531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer.
    Hashimoto K; Aoyagi K; Isobe T; Kouhuji K; Shirouzu K
    Gastric Cancer; 2014 Jan; 17(1):97-106. PubMed ID: 23558457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
    Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
    Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer.
    Wang Q; Chen ZG; Du CZ; Wang HW; Yan L; Gu J
    Histopathology; 2009 Sep; 55(3):284-93. PubMed ID: 19723143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of CD133 expression in gastric carcinoma.
    Ishigami S; Ueno S; Arigami T; Uchikado Y; Setoyama T; Arima H; Kita Y; Kurahara H; Okumura H; Matsumoto M; Kijima Y; Natsugoe S
    Anticancer Res; 2010 Jun; 30(6):2453-7. PubMed ID: 20651407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
    Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
    Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of expression of CD133 and Ki-67 in gastric cancer.
    Saricanbaz I; Karahacioglu E; Ekinci O; Bora H; Kilic D; Akmansu M
    Asian Pac J Cancer Prev; 2014; 15(19):8215-9. PubMed ID: 25339008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
    Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
    Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cancer stem cell marker CD133 expression in gastric cancer: a systematic review.
    Wen L; Chen XZ; Yang K; Chen ZX; Zhang B; Chen JP; Zhou ZG; Mo XM; Hu JK
    PLoS One; 2013; 8(3):e59154. PubMed ID: 23533603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
    Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
    Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
    Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
    Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer.
    Wakamatsu Y; Sakamoto N; Oo HZ; Naito Y; Uraoka N; Anami K; Sentani K; Oue N; Yasui W
    Pathol Int; 2012 Feb; 62(2):112-9. PubMed ID: 22243781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
    Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
    Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.